Curis Consents First Six Patients in TakeAim CLL Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Curis, Inc. (NASDAQ: CRIS) | Delayed: 0.66 +0.06 (10.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $3.70 | |||
| Open | $0.58 | 52 Week Low | $1.25 | |||
| Day High | $0.76 | P/E | N/A | |||
| Day Low | $0.57 | EPS | $-0.15 | |||
| Volume | 1,094,819 | |||||
